used in regular Chinese, Ayurvedic, and Thai medication. Conolidine could represent the beginning of a new era of Continual pain management. Now it is being investigated for its outcomes over the atypical chemokine receptor (ACK3). Inside a rat model, it had been identified that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3